Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Vicarious Surgical makes a single-port surgical robot that lets surgeons perform minimally invasive operations through one small incision.
Vicarious Surgical is a surgical robotics company building a robot that surgeons use to operate inside a patient's belly through a single tiny cut. Instead of opening someone up with a large incision, a surgeon sits at a console and controls two slender robotic arms that go in through one port, guided by a camera. The pitch is less trauma, faster recovery, and better outcomes for patients.

The company is going after the same broad prize as Intuitive Surgical, whose da Vinci system dominates surgical robotics. But Vicarious is betting on a different design: one port instead of several, and arms that mimic the surgeon's own movements more naturally. Hospitals and surgeons are the customers — the people who would buy or lease the system and use it in operating rooms. Here is the honest part. Vicarious Surgical is still a pre-revenue, development-stage company. As of recent public updates it has not yet won the regulatory clearances needed to sell its robot in the U.S., so it has been burning cash to finish development and run the clinical and regulatory work. That means the business today is really a bet on a future product, funded by investors, not a machine already generating sales.
Its shares trade on the OTC market rather than a major exchange, which is a sign of how early and speculative the story is. The whole thesis rests on whether the robot clears regulators and then convinces hospitals to choose it over the entrenched leader. If it works, it could open a new option in minimally invasive surgery; if it stalls, the cash burn is the risk.
Saved answer · last researched 16 Nov 2026